ClinicalTrials.gg
Status unknownNCT04734483Updated Feb 2, 2021

The Effectiveness of Reconstructive Microsurgery on the Clinical and Functional State of Laryngeal Stenosis

An interventional study of spirometry and MRI and CT in Larynx Disease and Laryngeal Stenosis, sponsored by Astana Medical University. Status unknown at 2 sites in 2 countries. Open to participants aged 1 Year to 74 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-02.

Sponsored by Astana Medical University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2021), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled May 2019, registered Dec 2020).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
1 Year to 74 Years
Sex
All
01

Study summary

To improve diagnostic methods for patients with laryngeal stenosis for the optimal determination of the technique of surgical treatment.

Read the detailed description

The study include patients with laryngeal pathology in the otorhinolaryngology clinic of the 1-city hospital at Nur-Sultan city. All patients cheek up the necessary clinical, functional, diagnostic studies and treatment measures. It is planned to examine and operate on 70 patients with laryngeal pathology.

  1. To study the features of the course of stenosis of the larynx under the influence of various factors, as well as traumatic injuries.
  2. To develop optimal diagnostic methods for patients with laryngeal stenosis.
  3. To assess the effectiveness of endolaryngeal microsurgery in patients with laryngeal stenosis.
  4. To develop recommendations for the organization of treatment for stenosis of the larynx with an increase its functional state.
02

Conditions studied

  • Larynx Disease
  • Laryngeal Stenosis

Browse trials for

Keywords

  • laryngeal stenosis
  • laryngeal MRI
  • laryngeal CT
  • pulmonary test
  • laryngoscopy
03

In context

Laryngeal Diseases

147 studies on the registry are indexed under Laryngeal Diseases; 26 are open to participants now.

This study's planned enrollment of 70 is above the median of 50 across 109 interventional studies indexed under Laryngeal Diseases.

Browse Laryngeal Diseases studies →

Lead sponsor

Astana Medical University is the lead sponsor of 16 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 74 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • medically diagnosed with stenosis of larynx
  • patients who were observed larynx by MRI and CT
  • patients who need surgical treatment of stenosis of larynx

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • patients who has positive electromyography findings of motion of laryngeal muscles
  • patients who has to surgical treatment on the other diseases
  • patients who has not normal results of lab. analyses
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Active comparator
    functional findings

    Participants with laryngeal stenosis

    Diagnostic Test: spirometry

  • Active comparator
    to find anatomic feathers of larynx

    Participants with laryngeal stenosis

    Radiation: MRI and CT · Other: Laryngoscopy

  • Active comparator
    to determine the type of stenosis of larynx and method of surgical treatment

    Participants with laryngeal stenosis

    Diagnostic Test: spirometry · Radiation: MRI and CT · Other: Laryngoscopy · Other: electromyography

  • Active comparator
    determining the motor abilities of the muscles of the larynx

    Participants with laryngeal stenosis

    Other: electromyography

Interventions

  • Diagnostic testspirometry

    spirometry

  • RadiationMRI and CT

    MRI and CT

  • OtherLaryngoscopy

    laryngoscopy

  • Otherelectromyography

    electromyography

06

What researchers measure

Primary outcomes

  1. Change from baseline forced expiratory volume

    Spirometry

    Time frame: at baseline and at 24-week postrandomization

  2. Change from baseline area between vocal cords

    MRI and CT of larynx

    Time frame: at baseline and at 24-week postrandomization

  3. Change from basiline vocal fold vibration

    Laryngoscopy and stroboscopy

    Time frame: at baseline and at 24-week postrandomization

  4. Evaluate the motor system by recording action potential generated in muscle fibres like thyroarytenoid, lateral cricoarytenoid, posterior cricoarytenoid, interarytenoid, cricothyroid.

    Electromyography

    Time frame: at baseline

07

Study locations

2 of 2 sites recruiting
  • Astana Medical University
    Astana, 010000, Kazakhstan
    Recruiting
    • Rais Tulebaev, Professor · Contactrais007@rambler.ru · +77017104509
    • Aliya Turayeva, PhD · Contactcvetalnur@mail.ru · +77073681054
    • Amanjol Baymenov, Docent · Sub investigator
  • Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech
    Saint Petersburg, 190013, Russian Federation
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2019 (actual). Primary completion is estimated for May 2021, 24 months after the start.

Of 29 interventional studies with no phase under Laryngeal Diseases, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's planned 24 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 3, 2020
First posted
Feb 2, 2021
StartActual
May 1, 2019
Primary completionEst.
May 1, 2021
CompletionEst.
Jun 1, 2021
Last update
Feb 2, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04734483
Lead sponsor
Astana Medical University
Responsible party
Sponsor
First posted
Feb 2, 2021
Start date
May 1, 2019
Primary completion
May 1, 2021 (estimated)
Completion
Jun 1, 2021 (estimated)
Last update
Feb 2, 2021

Study contacts

Aliya Turayeva, PhD
Contact
cvetalnur@mail.ru
+77073681054
Aliya Turayeva, PhD
principal investigator · Astana Medical Academy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion